# Center of Research Translation (CORT) Project 2

> **NCT02038179** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 99 (actual)

## Conditions studied

- Pre-hypertension
- JNC 7 Stage I Hypertension

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02038179
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02038179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02038179, "Center of Research Translation (CORT) Project 2". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02038179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
